• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer.胰岛素样生长因子信号受 microRNA-486 调控,microRNA-486 在肺癌中表达不足。
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15043-8. doi: 10.1073/pnas.1307107110. Epub 2013 Aug 26.
2
miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor.miR-140 通过靶向胰岛素样生长因子 1 受体抑制非小细胞肺癌的肿瘤生长和转移。
PLoS One. 2013 Sep 10;8(9):e73604. doi: 10.1371/journal.pone.0073604. eCollection 2013.
3
MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.微小RNA-139-5p通过靶向胰岛素样生长因子1受体抑制人非小细胞肺癌的细胞增殖和侵袭。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3864-70. eCollection 2015.
4
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
5
The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.新型 hsa-miR-12528 通过靶向 IGF-1R 抑制 AKT 级联的低磷酸化从而调控人肺癌的肿瘤发生和转移。
Cell Death Dis. 2018 May 1;9(5):493. doi: 10.1038/s41419-018-0535-8.
6
IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.IGF1/IGF1R 和 microRNA let-7e 相互下调,调节结直肠癌细胞的增殖和迁移。
Cell Cycle. 2018;17(10):1212-1219. doi: 10.1080/15384101.2018.1469873. Epub 2018 Jul 18.
7
microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.微小RNA-128通过直接靶向血管内皮生长因子-C,在人类非小细胞肺癌的肿瘤发生、血管生成和淋巴管生成中发挥关键作用。
Eur J Cancer. 2014 Sep;50(13):2336-50. doi: 10.1016/j.ejca.2014.06.005. Epub 2014 Jul 4.
8
MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R.微小RNA-195通过靶向胰岛素样生长因子1受体抑制非小细胞肺癌细胞的生长和转移。
Tumour Biol. 2014 Sep;35(9):8765-70. doi: 10.1007/s13277-014-2140-5. Epub 2014 May 30.
9
Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.微小RNA-206对c-Met和Bcl2的下调作用可激活细胞凋亡,并抑制肿瘤细胞的增殖、迁移和集落形成。
Oncotarget. 2015 Sep 22;6(28):25533-74. doi: 10.18632/oncotarget.4575.
10
Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.人源微小RNA-329通过下调非小细胞肺癌中的MET发挥肿瘤抑制功能。
Oncotarget. 2016 Apr 19;7(16):21510-26. doi: 10.18632/oncotarget.7517.

引用本文的文献

1
Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs.外泌体 miRNAs 对非小细胞肺癌致癌 LINE-1 调控网络的调控作用。
Int J Mol Sci. 2024 Oct 3;25(19):10674. doi: 10.3390/ijms251910674.
2
Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer.微小 RNA 作为非小细胞肺癌治疗性生物标志物的前景。
Med Oncol. 2023 Nov 3;40(12):345. doi: 10.1007/s12032-023-02212-5.
3
Regulation of IGF1R by MicroRNA-15b Contributes to the Anticancer Effects of Calorie Restriction in a Murine C3-TAg Model of Triple-Negative Breast Cancer.微小RNA-15b对IGF1R的调控有助于热量限制在三阴性乳腺癌小鼠C3-TAg模型中的抗癌作用。
Cancers (Basel). 2023 Aug 29;15(17):4320. doi: 10.3390/cancers15174320.
4
MicroRNAs as novel biomarkers for the diagnosis and treatment of pediatric diseases.微小RNA作为儿科疾病诊断和治疗的新型生物标志物。
Clin Exp Pediatr. 2024 Mar;67(3):119-125. doi: 10.3345/cep.2023.00171. Epub 2023 May 24.
5
Orchestration of miRNA Patterns by Testosterone and Dietary Tomato Carotenoids during Early Prostate Carcinogenesis in TRAMP Mice.雄激素和膳食番茄类胡萝卜素在 TRAMP 小鼠早期前列腺癌发生过程中对 miRNA 模式的调控。
J Nutr. 2023 Jul;153(7):1877-1888. doi: 10.1016/j.tjnut.2023.05.015. Epub 2023 May 13.
6
Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era.不同的液体活检在突变肿瘤学时代用于非小细胞肺癌的管理。
Med Sci (Basel). 2023 Jan 4;11(1):8. doi: 10.3390/medsci11010008.
7
Dehydroepiandrosterone inhibits vascular proliferation and inflammation by modulating the miR-486a-3p/NLRP3 axis.脱氢表雄酮通过调节miR-486a-3p/NLRP3轴抑制血管增殖和炎症。
Am J Transl Res. 2022 Sep 15;14(9):6123-6136. eCollection 2022.
8
miRNA-486-5p: signaling targets and role in non-malignant disease.miRNA-486-5p:信号靶标及其在非恶性疾病中的作用。
Cell Mol Life Sci. 2022 Jun 22;79(7):376. doi: 10.1007/s00018-022-04406-y.
9
LncRNA PCAT7 promotes non-small cell lung cancer progression by activating miR-486-5p/CDK4 axis-mediated cell cycle.长链非编码RNA PCAT7通过激活miR-486-5p/CDK4轴介导的细胞周期促进非小细胞肺癌进展。
Am J Transl Res. 2022 May 15;14(5):3003-3016. eCollection 2022.
10
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.微小RNA-486-5p通过p85/蛋白激酶B途径靶向CD133+肺癌干细胞。
Pharmaceuticals (Basel). 2022 Feb 28;15(3):297. doi: 10.3390/ph15030297.

本文引用的文献

1
Clinical applications for microRNAs in cancer.微小 RNA 在癌症中的临床应用。
Clin Pharmacol Ther. 2013 Jan;93(1):98-104. doi: 10.1038/clpt.2012.192. Epub 2012 Dec 5.
2
Modulation of the osteosarcoma expression phenotype by microRNAs.微小 RNA 对骨肉瘤表达表型的调控。
PLoS One. 2012;7(10):e48086. doi: 10.1371/journal.pone.0048086. Epub 2012 Oct 25.
3
MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.miR-122 通过靶向 IGF1R 抑制乳腺癌细胞增殖和肿瘤生成。
PLoS One. 2012;7(10):e47053. doi: 10.1371/journal.pone.0047053. Epub 2012 Oct 8.
4
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.miR-148a/152 和 DNMT1 的调控回路通过 IGF-IR 和 IRS1 调节细胞转化和肿瘤血管生成。
J Mol Cell Biol. 2013 Feb;5(1):3-13. doi: 10.1093/jmcb/mjs049. Epub 2012 Aug 29.
5
MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer.胰腺癌患者诊断性针吸抽吸物的 microRNA 分析。
Br J Cancer. 2012 Oct 9;107(8):1354-60. doi: 10.1038/bjc.2012.383. Epub 2012 Aug 28.
6
Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer.微小RNA在肺癌诊断和预后中的应用
Expert Opin Med Diagn. 2012 May;6(3):197-207. doi: 10.1517/17530059.2012.672970.
7
Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target.克唑替尼治疗间变性淋巴瘤激酶阳性非小细胞肺癌:一个新靶点的新型靶向治疗药物。
Clin Cancer Res. 2012 Jul 15;18(14):3737-42. doi: 10.1158/1078-0432.CCR-11-2393. Epub 2012 Apr 30.
8
MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.miR-145 调节肝癌中胰岛素样生长因子通路的多个成分。
Carcinogenesis. 2012 Jun;33(6):1134-41. doi: 10.1093/carcin/bgs130. Epub 2012 Mar 19.
9
The insulin and insulin-like growth factor receptor family in neoplasia: an update.肿瘤中胰岛素和胰岛素样生长因子受体家族:更新。
Nat Rev Cancer. 2012 Feb 16;12(3):159-69. doi: 10.1038/nrc3215.
10
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.厄洛替尼对比标准化疗用于治疗欧洲晚期 EGFR 突变阳性非小细胞肺癌患者的一线治疗(EURTAC):一项多中心、开放标签、随机、3 期临床试验。
Lancet Oncol. 2012 Mar;13(3):239-46. doi: 10.1016/S1470-2045(11)70393-X. Epub 2012 Jan 26.

胰岛素样生长因子信号受 microRNA-486 调控,microRNA-486 在肺癌中表达不足。

Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer.

机构信息

Department of Molecular Virology, Immunology, and Medical Genetics and Division of Hematology, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.

出版信息

Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15043-8. doi: 10.1073/pnas.1307107110. Epub 2013 Aug 26.

DOI:10.1073/pnas.1307107110
PMID:23980150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3773758/
Abstract

MicroRNAs (miRNAs) are small 19- to 24-nt noncoding RNAs that have the capacity to regulate fundamental biological processes essential for cancer initiation and progression. In cancer, miRNAs may function as oncogenes or tumor suppressors. Here, we conducted global profiling for miRNAs in a cohort of stage 1 nonsmall cell lung cancers (n = 81) and determined that miR-486 was the most down-regulated miRNA in tumors compared with adjacent uninvolved lung tissues, suggesting that miR-486 loss may be important in lung cancer development. We report that miR-486 directly targets components of insulin growth factor (IGF) signaling including insulin-like growth factor 1 (IGF1), IGF1 receptor (IGF1R), and phosphoinositide-3-kinase, regulatory subunit 1 (alpha) (PIK3R1, or p85a) and functions as a potent tumor suppressor of lung cancer both in vitro and in vivo. Our findings support the role for miR-486 loss in lung cancer and suggest a potential biological link to p53.

摘要

MicroRNAs (miRNAs) 是 19 到 24 个核苷酸的小非编码 RNA,具有调节癌症起始和进展所必需的基本生物过程的能力。在癌症中,miRNAs 可以作为癌基因或肿瘤抑制因子发挥作用。在这里,我们对 81 例 1 期非小细胞肺癌患者的 miRNA 进行了全面分析,并确定与相邻未受累肺组织相比,miR-486 在肿瘤中下调最为明显,提示 miR-486 的缺失可能在肺癌发生中很重要。我们报告说,miR-486 直接靶向胰岛素生长因子 (IGF) 信号通路的成分,包括胰岛素样生长因子 1 (IGF1)、IGF1 受体 (IGF1R) 和磷脂酰肌醇-3-激酶调节亚基 1 (alpha) (PIK3R1,或 p85a),并在体外和体内均作为肺癌的有效肿瘤抑制因子发挥作用。我们的研究结果支持 miR-486 缺失在肺癌中的作用,并提示与 p53 之间存在潜在的生物学联系。